Literature DB >> 1665829

Characterization of a 1,25-dihydroxy-vitamin D3 receptor in FRTL-5 cells. Evidence for an inhibitory effect of 1,25-dihydroxy-vitamin D3 on thyrotropin-induced iodide uptake.

C Lamberg-Allardt1, E Valtonen, M Polojärvi, P Stewen.   

Abstract

When FRTL-5 cell cytosol was incubated with increasing amounts of [3H]1,25-dihydroxy-vitamin D3 [( 3H]1,25-(OH)2D3), saturation of specific hormone binding occurred. Scatchard analysis of specific binding of [3H]1,25-(OH)2D3 to the macromolecule yielded an apparent Kd value of 0.41 +/- 0.08 X 10(-10) M and a single maximum binding capacity of 42.8 +/- 8.8 fmol/mg protein. Sucrose gradient analysis revealed substantial [3H]1,25-(OH)2D3 association with a macromolecule sedimentating slightly faster than ovalbumin (3.7 S). [3H]1,25-(OH)2D3 was completely displaced by excess 1,25-(OH)2D3. The 1,25-(OH)2D3-receptor complex bound to DNA cellulose columns in low salt buffer, and eluted as a single peak at 0.15-0.20 M KCl. Thus, we have shown for the first time the existence of a functional 1,25-(OH)2D3 receptor in thyroid follicular cells. Furthermore, 1,25-(OH)2D3 inhibited the thyrotropin (TSH)-stimulated iodide uptake in a dose-dependent manner, indicating that 1,25-(OH)2D3 has an effect on the physiological function of rat thyroid follicular cells in culture.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665829     DOI: 10.1016/0303-7207(91)90201-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  The vitamin d receptor in thyroid development and function.

Authors:  Isabelle Clinckspoor; Anne-Catherine Gérard; Jacqueline Van Sande; Marie-Christine Many; Lieve Verlinden; Roger Bouillon; Geert Carmeliet; Chantal Mathieu; Annemieke Verstuyf; Brigitte Decallonne
Journal:  Eur Thyroid J       Date:  2012-09-22

2.  Vitamin D receptor and progesterone receptor protein and gene expression in papillary thyroid carcinomas: associations with histological features.

Authors:  M P Yavropoulou; G Panagiotou; K Topouridou; G Karayannopoulou; T Koletsa; T Zarampoukas; A Goropoulos; E Chatzaki; J G Yovos; K Pazaitou-Panayiotou
Journal:  J Endocrinol Invest       Date:  2017-06-06       Impact factor: 4.256

Review 3.  Vitamin D and thyroid disease: to D or not to D?

Authors:  G Muscogiuri; G Tirabassi; G Bizzaro; F Orio; S A Paschou; A Vryonidou; G Balercia; Y Shoenfeld; A Colao
Journal:  Eur J Clin Nutr       Date:  2014-12-17       Impact factor: 4.016

4.  Vitamin D deficiency modulates Graves' hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization.

Authors:  Alexander Misharin; Martin Hewison; Chun-Rong Chen; Venu Lagishetty; Holly A Aliesky; Yumiko Mizutori; Basil Rapoport; Sandra M McLachlan
Journal:  Endocrinology       Date:  2008-10-16       Impact factor: 4.736

5.  Association of Low Serum 25OHD Levels with Abnormal Bone Microarchitecture in Well-Differentiated Thyroid Cancer.

Authors:  Federico Hawkins Carranza; Sonsoles Guadalix Iglesias; María Luisa De Mingo Dominguez; Gonzalo Allo Miguel; Cristina Martín-Arriscado Arroba; Begoña López Alvares; Guillermo Martínez Diaz-Guerra
Journal:  Med Sci (Basel)       Date:  2020-12-01

Review 6.  Relationship Between Vitamin D and Thyroid: An Enigma.

Authors:  Tejaswini Ashok; Vishnu Palyam; Ahmad T Azam; Oladipo Odeyinka; Rasha Alhashimi; Sankeerth Thoota; Ibrahim Sange
Journal:  Cureus       Date:  2022-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.